267
Participants
Start Date
September 8, 2010
Primary Completion Date
January 1, 2013
Study Completion Date
May 15, 2018
Pomalidomide 0.5 mg
Pomalidomide 0.5 mg capsule taken by mouth once daily. Immunomodulatory agent with demonstrated efficacy in the treatment of subjects with RBC-transfusion-dependence associated with MNP-associated myelofibrosis.
Placebo
Placebo Comparator to active drug; Placebo capsule taken by mouth once daily
Pomalidomide
Pomalidomide 0.5 mg capsule taken by mouth once daily.
Royal North Shore Hospital, St Leonards
Gosford Hospital, Gosford
Universitaire Ziekenhuis Leuven Gathuisberg, Leuven
Royal Melbourne Hospital, Parkville
Frankston Hospital, Frankston
Grand Hopital de Charleroi, Charleroi
Algemeen Ziekenhuis Sint-Jan, Bruges
Weill Medical College of Cornell University, New York
Ruttenberg Treatment Center, New York
Azienda Ospedaliera San Luigi Gonzaga, Orbassano
Memorial Sloan Kettering Cancer Center, New York
Mount Sinai School of Medicine Brookdale University Hospital, Brooklyn
Karolinska University Hospital Huddinge, Stockholm
Thomas Jefferson University, Philadelphia
Ospedale di Circolo e Fondazione Macchi Varese, Varese
Skane University Hospital, Lund
Ospedali Riuniti di Bergamo, Bergamo
IRCCS Fondazione Policlinico San Matteo, Universita di Pavia, Centro per lo Studio della Mielofibrosi, Pavia
IRCCS Fondazione Policlinico San Matteo, Universita di Pavia, Ematologia, Pavia
Hospital Universitario Puerta De Hierro Majadahonda, Majadahonda
Medizinische Hochschule Hannover, Hanover
Hopital Purpan, Toulouse
Mayo Clinic, Jacksonville
Johannes Wesling Klinikum Minden, Minden
University of Florida Shands Cancer Center, Gainesville
CHRU - Hopital du Haut Leveque, Pessac
Hospital Clinico de Salamanca, Salamanca
Hopital Albert Michallon, La Tronche
Medicine Taussig Cancer Institute, Cleveland
Hospital Clinico de Valencia, Valencia
University of Michigan Comprehensive Cancer Center, Ann Arbor
Azienda Ospedaliera Universitaria Careggi, Florence
Universitatsklinikum Aachen, Aachen
Mayo Clinic, Rochester
Avera Hematology and Transplant, Sioux Falls
Hopital Saint Vincent de Paul, Lille
University of Illinois at Chicago, Chicago
Hopitaux Universitaires de Strasbourg, CHU Haute-Pierre, Strasbourg
Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari
Hopital Saint-Louis, Paris
MD Anderson Cancer Center, Houston
Azienda Ospedaliera Universitaria Federico II di Napoli, Napoli
University of Utah, Salt Lake City
Mayo Clinic, Scottsdale
CHU Dupuytren, Limoges
Universitatsklinikum Ulm, Ulm
UCLA School of Medicine, Los Angeles
Institut Gustave Roussy, Villejuif
Fred Hutchinson Cancer Center, Seattle
Peking University People's Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Russian Scientific Haematology Centre, Moscow
Federal State Institution Russian Scientific-research Institute of Hematology and Transfusiology of Federal Medical-Biological Agency of Russia, Saint Petersburg
State Pavlov Medical University, Saint Petersburg
"Federal State Institution Federal Centre of Heart, Blood and Endocrinology of Rosmedtechnologies named after V.A. Almazov", Saint Petersburg
Shanghai Ruijin Hospital, Shanghai
Jiangsu Province Hospital, Jiangsu
Blood Disease Hospital Chinese Academy of Medical Sciences, Tianjin
West China Hospital, Sichuan University, Sichuan
Medizinische Universitatklinik Graz, Graz
Medizinische Universitat Innsbruck, Innsbruck
Medizinische Universitat Wien, Vienna
Cross Cancer Institute, Edmonton
Vancouver General Hospital, Vancouver
Princess Margaret Hospital, Toronto
Centre Hospitalier de L'Universite de Montreal, Montreal
Universitatsklinikum Leipzig, Leipzig
Juntendo University Hospital, Bunkyou-ku
Kyushu University Hospital, Fukuoka
Tokai University Hospital, Isehara
Kyoto University Hospital, Kyoto
Nagasaki University Hospital, Nagasaki
Tokyo Medical University Hospital, Shinjuku
VU University Medical Center, Amsterdam
Erasmus Medish Centrum, Rotterdam
University Medical Center Utrecht, Utrecht
Wojewodzki Szpital Specjalistyczny im. F.Chopina, Rzeszów
Samodzielny Publiczny Szpital Kliniczny Nr 1 PAM, Szczecin
Centralny Szpital Kliniczny MSWiA, Warsaw
Hospital Clinic I Provincial de Barcelona, Barcelona
Belfast City Hospital, Belfast
Beatson Oncology Centre, Glasgow
John Radcliffe Hospital NHS Trust, Headington
St. Thomas Hospital, London
Hammersmith Hospital, London
Freeman Hospital, Newcastle upon Tyne
Royal Hallamshire Hospital, Sheffield
Lead Sponsor
Celgene
INDUSTRY